Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New vaccines against tuberculosis.

T Mark Doherty1

  • 1Department of TB Immunology, Statens Serum Institute, Copenhagen, Denmark. tmd@ssi.dk

Tropical Medicine & International Health : TM & IH
|July 2, 2004
PubMed
Summary

New tuberculosis (TB) vaccines show promise in animal models and are entering human trials. This review covers advances in TB vaccine development, focusing on challenges for deployment in Africa.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related changes in the immune system and challenges for the development of age-specific vaccines.

Annals of medicine·2025
Same author

Role of new vaccinators/pharmacists in life-course vaccination.

Annals of medicine·2024
Same author

Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysis.

BMC public health·2024
Same author

Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key Concepts.

Vaccines·2024
Same author

Nonstructural barriers to adult vaccination.

Human vaccines & immunotherapeutics·2024
Same author

Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to action.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2024

Area of Science:

  • Global Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Communicable diseases hinder development in poorer countries.
  • Tuberculosis (TB), malaria, and HIV are major global health challenges.
  • The European Commission convened a round table in 2000 to address these issues.

Purpose of the Study:

  • To review recent advances in tuberculosis vaccine development.
  • To address issues concerning the testing and deployment of new TB vaccines in Africa, as discussed at the Gorée meeting.
  • To highlight the progress of novel TB vaccine candidates entering human clinical trials.

Main Methods:

  • Review of recent scientific literature on tuberculosis vaccine development.
  • Summary of outcomes and discussions from the Gorée workshop on TB in Africa.
  • Analysis of data from preclinical studies (animal models) and early-stage human trials.

Main Results:

  • Several new TB vaccine candidates (recombinant MVA and BCG, fusion proteins, peptide constructs) show promise.
  • These candidates have demonstrated efficacy in animal models, including non-human primates.
  • The vaccines are reported to be strongly immunogenic and apparently safe in preclinical studies.

Conclusions:

  • Human clinical trials for safety and efficacy of new TB vaccines are the logical next step.
  • Successful deployment of next-generation TB vaccines in Africa requires addressing specific challenges.
  • Continued research and development are crucial for effective TB control in endemic regions.

Related Experiment Videos